ReShape Lifesciences Inc.
At Close: 4:00 PM
Pre Market: 5:31 AM
RSLS Stock Price Graph
RSLS Stock Price Today
ReShape Lifesciences Inc. (RSLS) stock declined over -3.16% intraday to trade at $0.5911 a share on NASDAQ. The stock opened with a gain of 0.84% at $0.62 and touched an intraday high of $0.63, falling -3.10% against the last close of $0.61. The ReShape Lifesciences Inc. in stock market went to a low of $0.59 during the session.
RSLS Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
RSLS Stock Price History Chart
ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract. It also offers ReShapeCare virtual health coaching program, a virtual telehealth weight management program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.
Frequently Asked Questions
What is the current ReShape Lifesciences Inc. (RSLS) stock price?
ReShape Lifesciences Inc. (NASDAQ: RSLS) stock price is $0.59 in the last trading session. During the trading session, RSLS stock reached the peak price of $0.63 while $0.59 was the lowest point it dropped to. The percentage change in RSLS stock occurred in the recent session was -3.16% while the dollar amount for the price change in RSLS stock was -$0.02.
RSLS's industry and sector of operation?
The NASDAQ listed RSLS is part of Medical Devices industry that operates in the broader Healthcare sector. ReShape Lifesciences Inc. , a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally.
Who are the executives of RSLS?
Mr. Al Diaz
Vice President of Operations and R&D
Mr. Paul F. Hickey
Chief Executive Officer, Pres & Director
Dr. Mark B. Knudson Ph.D.
Co-Founder and Special Advisor to the Chief Executive Officer
Dr. Dov Gal D.V.M., DVM, M.B.A., MBA
Vice President of Regulatory Clinical Quality & Compliance Officer
How RSLS did perform over past 52-week?
RSLS's closing price is 0.08% higher than its 52-week low of $0.57 where as its distance from 52-week high of $22.4 is -0.95%.
How many employees does RSLS have?
Number of RSLS employees currently stands at N/A. RSLS operates from 1001 Calle Amanecer, San Clemente, CA 92673, US.
Link for RSLS official website?
Official Website of RSLS is: https://www.reshapelifesciences.com
How do I contact RSLS?
How many shares of RSLS are traded daily?
RSLS stock volume for the day was 56249.00 shares. The average number of RSLS shares traded daily for last 3 months was 151.6 Thousands.
What is the market cap of RSLS currently?
The market value of RSLS currently stands at $2.04 Million with its latest stock price at $0.59 and N/A of its shares outstanding.